Berkshire Hathaway TEVA-OLD trades
Warren Buffett
Warren Buffett Teva Pharma Industries Ltd ADR stake
total: 135
Trades details
- Total transactions:
- 5
- New positions:
- 1
- Sold out:
- 1
- Added:
- 2
- Reduced:
- 1
- Held since:
- 2017 Q4
- Held for:
- 16 quarters
- Latest activity:
- 2021 Q4
According to 2026 Q2 report, Warren Buffett doesn't hold any Teva Pharma Industries Ltd ADR (TEVA-OLD) shares. To date, the estimated cost basis is nearly $18.36 for "buy" trades and estimated average "sell" price is $9.73. Berkshire Hathaway first purchased TEVA-OLD in 2017 Q4, initially acquiring about 18.88M shares. Since the initial investment in Teva Pharma Industries Ltd ADR (TEVA-OLD), Berkshire Hathaway has made 4 more transactions.
When did Warren Buffett sell Teva Pharma Industries Ltd ADR (TEVA-OLD)?
Warren Buffett sold off the entire Teva Pharma Industries Ltd ADR (TEVA-OLD) position in 2021 Q4.
When did Warren Buffett buy Teva Pharma Industries Ltd ADR (TEVA-OLD)?
Warren Buffett first invested in Teva Pharma Industries Ltd ADR (TEVA-OLD) in 2017 Q4 at the reported quarter-end price of $18.95 per share.
What's the cost basis of Berkshire Hathaway's TEVA-OLD stake?
The estimated cost basis for Teva Pharma Industries Ltd ADR (TEVA-OLD) stake is around $18.36 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $18.36
- Weighted AVG sell price:
- $9.73
Warren Buffett's historical trades in Teva Pharma Industries Ltd ADR
5 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2021 Q4
|
0.00%
|
0
|
$9.74
|
|
-100% (-42,789,295)
|
-0.14%
|
|
2020 Q1
|
0.22%
|
$8.98
|
-1.06% (-460,000)
|
|||
|
2018 Q2
|
0.54%
|
$24.32
|
+6.68% (+2,709,585)
|
|||
|
2018 Q1
|
0.37%
|
$17.09
|
+114.77% (+21,663,989)
|
|||
|
2017 Q4
|
0.19%
|
$18.95
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.